The structure of mycoplanecin A was determined by the analysis of chemical degradation products and by mass and 1H and 13C NMR spectrometries.
fled by conventional analysis.
Amino acid-constituents were separately isolated from the acid hydrolysate by column chromatography on Sephadex G-10 equilibrated with the upper layer of a solvent mixture (BuOH -AcOH -H2O, 4: 1: 5). Each amino acid was further purified by rechromatography on a Sephadex G-10 column under the same conditions as described above.
Identification of the N-methyl amino acids, N-methylvaline, N-methylleucine and N-methylthreonine, was carried out by mass spectral analysis of the derivatives obtained after trimethylsilylation3.4) followed by treatment with N-methyl bistrifluoroacetamide.
The mass spectra of the derivatives of authentic leucine and N-methylvaline were recorded under the same conditions.
The ion intensities at m/z 158 of trimethylsilyl derivatives of leucine and N-methylvaline were very strong, while the ion intensity at m/z 182 of the N-trifluoroacetyl-O-trimethylsilyl derivative of N-methylvaline was much stronger than that of leucine (Scheme 2). A similar behavior in ion intensities was observed for the other N-methyl amino acids.
Such comparative studies by GC/MS spectral analysis and other spectral data were used for identification.
Molecular formula of compound 8, one of the unknown amino acids, was determined to be C,H1,-NO. from high resolution GC/MS data of its trimethylsilyl derivative. The 1H NMR spectrum of 8 indicated the presence of an isopropyl, two methylene and one methine groups. Therefore, compound 8 was logically identified as 2-amino-5-methyl hexanoic acid, which was deduced to be the L-isomer by the similarity of its specific rotation to that of L-leucine. The fragmentation pattern of the GC/MS spectrum is shown in Scheme 3. 1H NMR and GC/MS spectra of compound 10 suggested its structure to be 4-ethylproline . As for the stereochemistry of compound 10, it was revealed to be trans-4-ethyl-L-proline by 1H NMR and CD spectra by comparison with those of compound 9 and by specific rotation data. The results of 1H NMR studies of compounds 9 and 10 are summarized in Table 1 .
The last constituent of 1, compound 11, C4H,Os (mol. wt. 102), was isolated from the acid hydrolysate of 1 on Dowex 50WX4 (H+) column. From the analysis of 1H NMR of compound 11 and GC/ MS of its ditrimethylsilyl derivative, the structure was determined to be a-ketobutyric acid. The data on The presence of a-ketobutyric acid moiety in 1 was supported by the following evidence: the 13C NMR spectrum of 1 indicated a signal at 201 ppm due to a ketone group, which shifted to 70 ppm by reduction of 1 with NaBH, in accordance with the isolation of a-hydroxybutyric acid (22) from the acid hydrolysate of the reduced product of 1,
Thus, all of the constituents of 1 were isolated and characterized as follows:
and a-ketobutyric acid.
Four N-methyl signals and 11 carbonyl carbons in 1H and 13C NMR spectra of 1 suggested that one of the three N-methyl amino acids described above could exist in two molar equivalents.
The next step of structural elucidation was achieved by isolation of the oligopeptides from either mild acidic or alkaline hydrolysates followed by analysis of their amino acid composition and sequence.
Partial hydrolysis in 6 N HCl was carried out at 37°C for 72 hours. The amino acid sequences of peptides are summarized in Table 2 . Reduction of 1 with NaBH, gave a major product (19) and minor compound ( The mass spectral analysis of trimethylsilyl derivatives of peptides (12, 13, 14 and 15) always gave a very stable ion peak at m/z 117 due to a fragment, CH3-CH =0+ -TMS, derived from the free hydroxyl group of the N-methylthreonine residue. However, the mass spectrum of the trimethylsilyl derivative of 1 did not show the fragment ion peak at m/z 117. Therefore, it was concluded that the hydroxyl group of N-methylthreonine residue in 1 was not in free form. Consequently, the structure of 1 was found to have a lactone linkage between the carboxyl group of glycine and the hydroxyl group of N-methylthreonine.
All evidences described above unequivocally led to the cyclic peptide structure (1) Mycoplanecin A is closely related to griselimycin, but clearly differs by its amino acid and fatty acid components. It appears that the difference between these two antibiotics lies in the presence in mycoplanecin A of 2-amino-5-methylhexanoic acid, ethylproline and a-ketobutyric acid which are replaced by leucine, methylproline and acetic acid in griselimycin.
Experimental
1H and 13C NMR spectra were taken with a Varian HA -100 (100 MHz) and a Varian XL-100 (25.2
MHz) spectometer, respectively. Electron impact mass spectra were measured on a JEOL-O1SG mass spectrometer using the direct-inlet probe and field desorption mass spectra on a double focusing JEOL-O1SG instrument equipped with a combined f. d. f. i. e. i. ion source. GC/MS spectra were combined with a JEOL JMS D-100. Amino acid analysis was carried out on a Hitachi KLA-5 automatic amino acid analyzer. Optical rotations were measured on a Perkin-Elmer 241 polarimeter. AUG. 1983 Acid Hydrolysis of 1 A 1 g sample of 1 was hydrolyzed in 20 ml of conc. HC1 -AcOH (1: 1) in a sealed tube for 20 hours at 105°C. The hydrolysate was concentrated several times from water under reduced pressure to remove excess acids. For separation of each amino acid the residue was subjected to a cellulose column (Avicel. Funakoshi Yakuhin Co., Ltd., Japan) packed and developed with 90% aqueous isopropanol followed by Sephadex G-10 column equilibrated with the upper layer of BuOH -AcOH -H2O ( Mild Acid Hydrolysis of 1 A 400 mg sample of 1 was hydrolyzed in 12 ml of 6 N HCI at 37°C. The hydrolysate was concentrated several times from water under vacuum to remove excess HC1. The residue was applied to a Sephadex G-10 column equilibrated and developed with the upper layer of BuOH -AcOH -H,O (4: 1: 5). The crude oligopeptides thus separated were purified on Sephadex G-10 column using the lower layer of BuOH -AcOH -H2O -CHCl3 (4: 1: 5: 2). Each peptide isolated on Sephadex G-10 column was subjected to preparative TLC on silica gel with BuOH -AcOH -H,O (4: 1: 2) and finally purified by adsorption on a small column of Dowex 50WX4 (H+) followed by elution with 0.5 N NH,OH. Isolated peptides were: compound 12, 43 mg; compound 13, 33. Reduction of 1 To a solution of 1 (2 g) dissolved in 20 ml of methanol was added 150 mg of NaBH4 upon stirring at 0°C for one hour. The reaction mixture was concentrated to dryness and the residue extracted with 50 ml of ethyl acetate after adjustment of the pH to 4.0. The extract was washed twice with 50 ml of saturated aqueous sodium chloride and evaporated to afford 2 g of the reaction product, which was treated with 10 ml of cold acetonitrile to give 1 g of dihydromycoplanecin A (19) as colorless needles.
The mother liquor was subjected to preparative TLC (CHC13 -MeOH, 4: 1) to afford 700 mg of the acidic substance as another product 20, which was treated with ethereal diazomethane to yield monomethyl ester (21). Compound 20 could also be obtained by treatment of 19 with 0.1 N NaOH at room temperature for one hour.
Preparation of 22 A 310 mg of 19 was hydrolyzed in 20 ml of cone. HCl -AcOH (1: 1) at 105°C for 20 hours. The hydrolysate was concentrated several times from water under reduced pressure to remove excess HCl and were applied on a column of Dowex 50WX4 (H+) (50 ml). The effluent and washings were combined and extracted twice with 50 ml of ethyl acetate. After washing with saturated aqueous sodium chloride the extract was dried over Na2SO4 and concentrated to give 13.4 mg of 22. C4H3O3 (mol. wt. 104), 114 NMR onpm" 0.85 (3H, t), 1.65 (2H, m) and 4.2 (1H, m).
